Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumorsSergio Pedraza‐Arévalo, Justo P. Castaño, Juan M. Jiménez‐Vacas et al.|Translational research|2022Cited by 22
Spliceosomic dysregulation unveils <i>NOVA1</i> as an actionable therapeutic target in pancreatic neuroendocrine tumorsSergio Pedraza‐Arévalo, Justo P. Castaño, Emilia Alors‐Pérez et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 0